Meeting of the
CDER Antiviral Drugs Advisory Committee
CONSULTANTS
AND GUESTS
Special Government Employee (SGE) Consultants
(Voting)
Robert
Grant M.D., M.P.H., M.S.
Associate
Professor of Medicine
Gladstone Institute of
Virology and Immunology
San Francisco, CA 94158
Director, Forum for
Collaborative HIV Research
The
Department
of Prevention and Community Health
Stephen Hall, Ph.D.
Professor of Medicine
Associate Clinical
Professor
Pediatric Pharmacology
Research Unit
9500 Gilman Drive
La Jolla, CA 92093-0979
Gene
Morse, Pharm.D.
Department of Pharmacy
Practice
317 Hochstetter
Hall
Government Employee Consultant (Voting)
HIV Drug Resistance Program, NCI,
NIH
Bldg. 10, Room 8C301
Special Government Employee (SGE) Consultant
(Non-voting)
Princy
Kumar, Ph.D
Chief, Associate Professor of Medicine
Division of Infectious Diseases
110 Kober-
SGE Patient Representative (Non-voting)
Lynda Dee, J.D., AIDS Action Baltimore,
FDA Participants at the Table (Non-voting)
Mark J. Goldberger, M.D.,
M.P.H.
Director, Office of Drug
Evaluation IV, CDER
Debra B. Birnkrant, M.D.
Director, Division of
Antiviral Drug Products, CDER
Rosemary Johann-Liang, M.D.
Medical Team
Leader, Division
of Antiviral Drug Products, CDER
Andrea James,
M.D.
Medical Officer,
Division of
Antiviral Drug Products, CDER